CLDN8 and nonpapillary renal cell carcinoma: Among the downregulated genes, PVALB passes through AKT/GSK-3β pathways that inhibit cell growth and induce cell death (26), and CLDN8 inhibits the proliferation, migration, and invasion of 786-O ccRCC cells through the EMT and AKT pathways (27).